Novo Nordisk Investigational Site

Curitiba 81050-090

0 studies enrolling now · 5 studies all time

What they study most

Chronic Kidney Disease, Diabetes, Diabetes Mellitus, Type 2, End-Stage Renal Disease, Inflammation, Metabolism and Nutrition Disorder, Obesity, Rheumatoid Arthritis

Studies at this site

• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results — Completed
• A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics — Stopped early
• A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate — Stopped early
• Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes — Completed
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis — Stopped early